Milla pharmaceuticals inc. and the alter pharma group announce launch of a generic version of magnesium sulfate in water for injection, in non-pvc, single-patient use containers by their partner athenex pharmaceutical division (apd)

Minnetonka, minn.--(business wire)--milla pharmaceuticals inc., a subsidiary of the alter pharma group, announced that its partner, athenex pharmaceutical division (apd), has just started to commercialize its abbreviated new drug application (anda) approval from the u.s.
ATNX Ratings Summary
ATNX Quant Ranking